A novel series of highly potent benzimidazole-based microsomal triglyceride transfer protein inhibitors

被引：52

作者：

Robl, JA ^{[1
]}

Sulsky, R ^{[1
]}

Sun, CQ ^{[1
]}

Simpkins, LM ^{[1
]}

Wang, T ^{[1
]}

Dickson, JK ^{[1
]}

Chen, Y ^{[1
]}

Magnin, DR ^{[1
]}

Taunk, P ^{[1
]}

Slusarchyk, WA ^{[1
]}

Biller, SA ^{[1
]}

Lan, SJ ^{[1
]}

Connolly, F ^{[1
]}

Kunselman, LK ^{[1
]}

Sabrah, T ^{[1
]}

Jamil, D ^{[1
]}

Gordon, D ^{[1
]}

Harrity, TW ^{[1
]}

Wetterau, JR ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 2001年 / 44卷 / 06期

关键词：

D O I：

10.1021/jm000494a

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of benzimidazole-based analogues of the potent MTP inhibitor EMS-201038 were discovered. Incorporation of an unsubstituted benzimidazole moiety in place of a piperidine group afforded potent inhibitors of MTP in vitro which were weakly active in vivo. Appropriate substitution on the benzimidazole ring, especially with small alkyl groups, led to dramatic increases in potency, both in a cellular assay of apoB secretion and especially in animal models of cholesterol lowering. The most potent in this series, 3g (BMS-212122), was significantly more potent than EMS-201038 in reducing plasma lipids (cholesterol, VLDL/LDL, TG) in both hamsters and cynomolgus monkeys.

引用

页码：851 / 856

页数：6

共 7 条

[1] Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly [J].

Gordon, DA ;

Jamil, H .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2000, 1486 (01) :72-83

[2] SYNTHESIS OF MUTAGENIC METHYL-SUBSTITUTED AND PHENYL-SUBSTITUTED 2-AMINO-3H-IMIDAZO[4,5-F]QUINOXALINES VIA 2,1,3-BENZOSELENADIAZOLES [J].

GRIVAS, S ;

TIAN, W ;

RONNE, E ;

LINDSTROM, S ;

OLSSON, K .

ACTA CHEMICA SCANDINAVICA, 1993, 47 (05) :521-528

[3] Drug treatment of lipid disorders [J].

Knopp, RH .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (07) :498-511

[4] Mortality by cause for eight regions of the world: Global Burden of Disease Study [J].

Murray, CJL ;

Lopez, AD .

LANCET, 1997, 349 (9061) :1269-1276

[5] Trends in the incidence of myocardial infarction and in mortality due to coronary heart disease, 1987 to 1994 [J].

Rosamond, WD ;

Chambless, LE ;

Folsom, AR ;

Cooper, LS ;

Conwill, DE ;

Clegg, L ;

Wang, CH ;

Heiss, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (13) :861-867

[6]

SEROUGNE C, 1995, J CLIN BIOCHEM NUTR, V18, P55

[7] An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits [J].

Wetterau, JR ;

Gregg, RE ;

Harrity, TW ;

Arbeeny, C ;

Cap, M ;

Connolly, F ;

Chu, CH ;

George, RJ ;

Gordon, DA ;

Jamil, H ;

Jolibois, KG ;

Kunselman, LK ;

Lan, SJ ;

Maccagnan, TJ ;

Ricci, B ;

Yan, MJ ;

Young, D ;

Chen, Y ;

Fryszman, OM ;

Logan, JVH ;

Musial, CL ;

Poss, MA ;

Robl, JA ;

Simpkins, LM ;

Slusarchyk, WA ;

Sulsky, R ;

Taunk, P ;

Magnin, DR ;

Tino, JA ;

Lawrence, RM ;

Dickson, JK ;

Biller, SA .

SCIENCE, 1998, 282 (5389) :751-754

← 1 →